Work

0736 Effect of the Oral Orexin Receptor 2 Agonist Oveporexton (TAK-861) on Quality of Life in Individuals with NT1: A Pooled Analysis of Phase 3 Studies

Year: 2026

Type: conference-abstract

Source: SLEEP

DOI: 10.1093/sleep/zsag091.0735

Authors: Rafael Del Rio Villegas, Sheila Sivam, Alice Cai, Yeting Du, Samuel Hsiao, Heather Romero, Tina Olsson, Giuseppe Plazzi

Institutions: Royal Prince Alfred Hospital, Woolcock Institute of Medical Research, Takeda (United States), Istituto delle Scienze Neurologiche di Bologna

Language: English

Topic: Sleep and Wakefulness Research

Subfield: Cognitive Neuroscience

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7160612700

Cites:

Cited by:

Related to: